Researchers@EVMS
Toggle navigation
Browse
Home
People
Departments
Research Areas
Capability Map
Publications
Events
Clinical Trials
Student Opportunities
FAQ
Final analysis results from TITAN: A phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT).
Meeting Abstract
Overview
Additional Document Info
View All
Overview
publication date
February 20, 2021
webpage
Web of Science
published in
JOURNAL OF CLINICAL ONCOLOGY
Journal
Additional Document Info
volume
39
issue
6